Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$190M |
| 2 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$178M |
| 3 |
Meta Platforms (Facebook)
META
|
+$172M |
| 4 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$169M |
| 5 |
Microsoft
MSFT
|
+$166M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$278M |
| 2 |
Intel
INTC
|
+$223M |
| 3 |
PPLI
People Inc
PPLI
|
+$210M |
| 4 |
Mastercard
MA
|
+$210M |
| 5 |
Honeywell
HON
|
+$188M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.25% |
| 2 | Healthcare | 9.18% |
| 3 | Consumer Discretionary | 6.93% |
| 4 | Technology | 6.31% |
| 5 | Industrials | 5.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Invesco S&P 500 Low Volatility ETF
SPLV
$7.03B
| $1.86M | ﹤0.01% |
+34,766
| New | +$1.85M |
|
|
THBRU
2602
DELISTED
Thunder Bridge Acquisition II, Ltd. Units
THBRU
| $1.86M | ﹤0.01% |
170,000
| – | – |
|
2603
Alaunos Therapeutics
TCRT
$4.32M
| $1.86M | ﹤0.01% |
4,931
-3,935
| -44% | -$1.74M |
|
|
ESPR
2604
CALL
DELISTED
Esperion Therapeutics
ESPR
| $1.86M | ﹤0.01% |
50,000
-50,000
| -50% | -$1.98M |
|
2605
UFP Industries
UFPI
$4.68B
| $1.86M | ﹤0.01% |
32,895
+17,225
| +110% | +$972K |
|
2606
Alphatec Holdings
ATEC
$1.47B
| $1.86M | ﹤0.01% |
279,761
+184,561
| +194% | +$1.04M |
|
2607
Vistra
VST
$46.4B
| $1.86M | ﹤0.01% |
98,503
-334,796
| -77% | -$6.31M |
|
2608
Veru
VERU
$45M
| $1.86M | ﹤0.01% |
70,834
+35,827
| +102% | +$1.04M |
|
2609
Nektar Therapeutics
NKTR
$2.45B
| $1.85M | ﹤0.01% |
7,445
+1,212
| +19% | +$381K |
|
2610
WisdomTree
WT
$3.82B
| $1.85M | ﹤0.01% |
578,686
+408,112
| +239% | +$1.47M |
|
2611
ICU Medical
ICUI
$4.38B
| $1.85M | ﹤0.01% |
10,098
-14,446
| -59% | -$2.72M |
|
|
GAP
2612
CALL
The Gap Inc
GAP
$8.5B
| $1.84M | ﹤0.01% |
108,200
-391,800
| -78% | -$5.84M |
|
|
SPNE
2613
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $1.84M | ﹤0.01% |
128,882
+35,340
| +38% | +$428K |
|
|
ADVM
2614
DELISTED
Adverum Biotechnologies
ADVM
| $1.84M | ﹤0.01% |
17,878
-9,418
| -35% | -$1.41M |
|
2615
iShares Semiconductor ETF
SOXX
$41.7B
| $1.84M | ﹤0.01% |
18,123
-102
| -0.6% | -$9.97K |
|
2616
CALL
Stellantis
STLA
$20.4B
| $1.83M | ﹤0.01% |
150,000
| – | – |
|
2617
Royalty Pharma
RPRX
$27.1B
| $1.83M | ﹤0.01% |
43,557
-678,245
| -94% | -$29.1M |
|
2618
Stagwell
STGW
$2.17B
| $1.83M | ﹤0.01% |
1,137,312
-88,726
| -7% | -$183K |
|
2619
DNOW Inc
DNOW
$2.87B
| $1.83M | ﹤0.01% |
+402,722
| New | +$3.06M |
|
2620
KLA
KLAC
$232B
| $1.83M | ﹤0.01% |
94,280
+28,940
| +44% | +$572K |
|
|
EMBJ
2621
Embraer S.A. ADS
EMBJ
$13.1B
| $1.82M | ﹤0.01% |
413,197
-1,106,746
| -73% | -$6.14M |
|
2622
Tetra Tech
TTEK
$9.41B
| $1.82M | ﹤0.01% |
95,275
-97,525
| -51% | -$1.73M |
|
2623
SelectQuote
SLQT
$93M
| $1.82M | ﹤0.01% |
89,772
-326,509
| -78% | -$6.8M |
|
2624
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.6B
| $1.81M | ﹤0.01% |
+33,321
| New | +$1.82M |
|
2625
Fortinet
FTNT
$120B
| $1.8M | ﹤0.01% |
76,620
-1,066,910
| -93% | -$27.6M |
|
Similar funds
Israel Englander's Q3 2020 Portfolio in Review
As of Q3 2020, Israel Englander held 5,106 positions worth $81.2B, up 11% from $73B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2020 filing shows 989 new, 1,503 increased, 1,793 reduced and 724 closed positions. Its largest new stake was Pershing Square Tontine Holdings, Ltd.: 5,275,934 shares worth $120M. The largest sale was JPMorgan Chase, an estimated $278M.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 47% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Israel Englander's largest Q3 2020 buy was Pershing Square Tontine Holdings, Ltd.: 5,275,934 shares worth $120M.
- Israel Englander added most to Varian Medical Systems, Inc. in Q3 2020, an estimated $190M increase.
- Israel Englander's biggest Q3 2020 reduction was JPMorgan Chase, cutting an estimated $278M.
- Israel Englander fully exited Tech Data Corp in Q3 2020, selling an estimated $186M.
- Israel Englander's ten largest holdings make up 18% of its $81.2B portfolio in Q3 2020.
- Israel Englander opened 989 new positions and closed 724 in Q3 2020.
- Israel Englander's portfolio value rose 11% quarter-over-quarter to $81.2B.
Based on Millennium Management's 13F filing for Q3 2020, filed 16 Nov 2020.